IRADIMED CORPORATION Proceeds from Stock Options Exercised
IRADIMED CORPORATION (IRMD) reported Proceeds from Stock Options Exercised of $29.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-03-06
- IRADIMED CORPORATION proceeds from stock options exercised for the quarter ending 2024-12-31 was $25.70K, a 84.83% decline year-over-year.
- IRADIMED CORPORATION proceeds from stock options exercised for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- IRADIMED CORPORATION proceeds from stock options exercised for the quarter ending 2023-12-31 was $169.40K, a 16940200.00% increase year-over-year.
- IRADIMED CORPORATION proceeds from stock options exercised for the quarter ending 2023-09-30 was $2.00, a 100.00% decline year-over-year.
- IRADIMED CORPORATION proceeds from stock options exercised for fiscal 2024 was $29.00K, a 83.59% decline from fiscal 2023.
- IRADIMED CORPORATION proceeds from stock options exercised for fiscal 2023 was $176.74K, a 20.47% increase from fiscal 2022.
- IRADIMED CORPORATION proceeds from stock options exercised for fiscal 2022 was $146.71K, a 76.46% decline from fiscal 2021.
- IRADIMED CORPORATION proceeds from stock options exercised for fiscal 2021 was $623.24K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $25.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $25.70K derived: sum of 2 quarters · filed 2026-03-06 | $29.00K 10-K · filed 2026-03-06 | $29.62K 10-K · filed 2025-03-06 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $3.30K 10-Q · filed 2025-11-03 | |||
| 2024-06-30 | $3.30K 10-Q · filed 2025-08-01 | ||||
| 2023-12-31 | $169.40K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03 | $169.41K derived: sum of 2 quarters · filed 2025-09-03 | $176.74K 10-K/A · filed 2025-09-03 | ||
| 2023-09-30 | $2.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $7.34K 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | $7.34K 10-Q · filed 2024-08-01 | ||||
| 2022-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $74.76K derived: sum of 2 quarters · filed 2024-03-01 | $74.76K derived: sum of 3 quarters · filed 2024-03-01 | $146.71K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $74.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $74.76K derived: sum of 2 quarters · filed 2023-11-03 | $146.71K 10-Q · filed 2023-11-03 | $684.33K derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $71.95K 10-Q · filed 2023-08-03 | $609.58K derived: sum of 3 quarters · filed 2023-08-03 | $672.50K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $71.95K 10-Q · filed 2023-05-04 | $609.58K derived: sum of 2 quarters · filed 2023-05-04 | $672.50K derived: sum of 3 quarters · filed 2023-05-04 | $692.73K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $537.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $600.55K derived: sum of 2 quarters · filed 2023-03-02 | $620.78K derived: sum of 3 quarters · filed 2023-03-02 | $623.24K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $62.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $83.16K derived: sum of 2 quarters · filed 2022-11-03 | $85.61K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $20.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $22.70K 10-Q · filed 2022-08-05 | |||
| 2021-03-31 | $2.46K 10-Q · filed 2022-05-06 | ||||
| 2020-09-30 | $931.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $1.40M derived: sum of 2 quarters · filed 2021-11-05 | $1.72M 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $468.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $790.99K 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $322.18K 10-Q · filed 2021-05-07 | ||||
| 2019-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.75M derived: sum of 2 quarters · filed 2020-11-06 | $2.21M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $43.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $500.25K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $456.74K 10-Q · filed 2020-05-07 | ||||
| 2018-06-30 | $139.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $235.08K 10-Q · filed 2018-08-08 | |||
| 2018-03-31 | $95.92K 10-Q · filed 2018-05-08 | ||||
| 2017-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $16.37K derived: sum of 2 quarters · filed 2018-08-08 | $49.46K 10-Q · filed 2017-11-06 | ||
| 2017-06-30 | $16.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $49.46K 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | $33.09K 10-Q · filed 2018-05-08 | ||||
| 2016-09-30 | $126.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $143.43K derived: sum of 2 quarters · filed 2017-11-06 | $217.01K 10-Q · filed 2017-11-06 | ||
| 2016-06-30 | $16.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $90.26K 10-Q · filed 2017-08-04 | |||
| 2016-03-31 | $73.59K 10-Q · filed 2017-05-05 | ||||
| 2015-09-30 | $121.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $128.97K derived: sum of 2 quarters · filed 2016-11-04 | $320.81K 10-Q · filed 2016-11-04 | ||
| 2015-06-30 | $7.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $199.06K 10-Q · filed 2016-08-05 | |||
| 2015-03-31 | $191.84K 10-Q · filed 2016-05-06 | ||||
| 2014-12-31 | $105.00K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |